Our Advisors
Our collective goal is to champion and advance research for a single purpose: to preserve and restore vision in people with diabetes. Meet our team:
External Scientific Advisory Board
Mark Atkinson, PhD
University of Florida, Director of University of Florida Diabetes Institute; Director, nPOD and CaRe-TID
Sally Baxter, MD
UCSD Shiley Eye Institute, Division Chief for Ophthalmology Informatics and Data Science
Dolly Chang, MD, MPH, PhD
Genentech, Senior Medical Director, Research and Early Development
Sanjoy Dutta, PhD
JDRF, Chief Scientific Officer
Stephen McLeod, MD
American Academy of Ophthalmology, CEO
Tunde Peto, MD, PhD
Queen’s University Belfast, Professor of Clinical Ophthalmology
Marlon Pragnell, PhD
American Diabetes Association, Vice President of Research and Science
Christopher Rhodes, PhD
AstraZeneca Chief Scientist/Vice President, Cardiovascular, Renal and Metabolic Disease, Biopharmaceuticals R&D
José Sahel, MD, PhD
University of Pittsburgh School of Medicine, Chair of Ophthalmology
Marie Schiller
Interim CEO, The Diabetes Link; former VP Drug Development/Device R&D Innovation, Eli Lilly and Company
Don Zack, MD, PhD
Co-Director, Johns Hopkins Center for Stem Cells and Ocular Regenerative Medicine
Lay Advisory Commitee
Chris German, PhD
Senior Scientist, Myriad Genetics | Person with Diabetes
Tom Chapman, MBA
CIO Teewinot Partners | Person with Diabetes
Judy Hunt, MBA
Diabetes Family Advocate
Monica Oxenreiter, MBA, MPP
VP of Close Concerns | Person with Diabetes
Sandra Puczynski, PhD
Diabetes Family Advocate
Join Our Email List
By submitting this form, you are consenting to receive marketing emails from: Mary Tyler Moore Vision Initiative. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact